GlaxoSmithKline, Vir target emergency authorization for intramuscular COVID-19 antibody drug with new trial win November 12, 2021 Auto Bot News 0 GlaxoSmithKline, Vir target emergency authorization for intramuscular COVID-19 antibody drug with new trial win aliu Fri, 11/12/2021 – 11:43